<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> patients <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> (TEEs) are described as possible complications at implant or during the follow-up </plain></SENT>
<SENT sid="1" pm="."><plain>We report four cases of TEEs (two peripheral and two cerebral; 6.5% of patients) that occurred in our series during a mean follow-up of 19.4 months </plain></SENT>
<SENT sid="2" pm="."><plain>The patients had <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0857175" disease_type="Disease or Syndrome" abbrv="">postinfarction</z:e> LV <z:hpo ids='HP_0002617'>aneurysm</z:hpo> (3) and idiopathic <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> (1) </plain></SENT>
<SENT sid="3" pm="."><plain>None had previous embolisms nor evidence of left atrial or LV clots at standard preoperative transthoracic echocardiography </plain></SENT>
<SENT sid="4" pm="."><plain>No paroxysms of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> were documented prior or after <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implant </plain></SENT>
<SENT sid="5" pm="."><plain>We discuss the possible causes of embolization and the suitability of <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> patients </plain></SENT>
</text></document>